APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GLP-1 Injection Market Analysis and Forecast 2026-2032

26 December 2025213 pages

Choose your research edition.

Industry ResearchGLP-1 Injection Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Injection Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal GLP-1 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Injection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global GLP-1 Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

GLP-1 Injection's global sales reached XX (Units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Zhengda Tianqing as the global sales leader, a title it has maintained for several consecutive years. Notably, Zhengda Tianqing's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Units), a change of XX% from the previous year. In Europe, sales were XX (Units), showing a year-on-year of XX%. In the US, sales were XX (Units), a year-on-year change of XX%.

The major global manufacturers in the GLP-1 Injection market include Zhengda Tianqing, Innovent Biologics, Wanbang Biopharma, Sihuan Pharmaceuticals, CSPC Pharmaceutical Group, Shanghai Benemae Biopharmaceuticals Co., Ltd., Pegbio, Eli Lilly and Huadong Medicine, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the GLP-1 Injection production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of GLP-1 Injection by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for GLP-1 Injection, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GLP-1 Injection, also provides the consumption of main regions and countries. Of the upcoming market potential for GLP-1 Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GLP-1 Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GLP-1 Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GLP-1 Injection sales, projected growth trends, production technology, application and end-user industry.

GLP-1 Injection Segment by Company

Zhengda Tianqing

Innovent Biologics

Wanbang Biopharma

Sihuan Pharmaceuticals

CSPC Pharmaceutical Group

Shanghai Benemae Biopharmaceuticals Co., Ltd.

Pegbio

Eli Lilly

Huadong Medicine

Hongyun Huaning

Hengrui Medicine

Hansoh Pharmaceuticals

Gan & Lee Pharmaceuticals

Borui Pharmaceuticals

Imeik

Novo Nordisk

GLP-1 Injection Segment by Type

Benaglutide

Liraglutide

Semaglutide

Tirzepatide

Others

GLP-1 Injection Segment by Application

Diabetes

Obesity

Others

GLP-1 Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: GLP-1 Injection production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of GLP-1 Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of GLP-1 Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GLP-1 Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GLP-1 Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Benaglutide Major Manufacturers Table 3. Liraglutide Major Manufacturers Table 4. Semaglutide Major Manufacturers Table 5. Tirzepatide Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global GLP-1 Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Diabetes Major Manufacturers Table 9. Obesity Major Manufacturers Table 10. Others Major Manufacturers Table 11. GLP-1 Injection Industry Trends Table 12. GLP-1 Injection Industry Drivers Table 13. GLP-1 Injection Industry Opportunities and Challenges Table 14. GLP-1 Injection Industry Restraints Table 15. Global GLP-1 Injection Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 16. Global GLP-1 Injection Production by Region (2021-2026) & (Units) Table 17. Global GLP-1 Injection Production by Region (2027-2032) & (Units) Table 18. Global GLP-1 Injection Production Market Share by Region (2021-2026) Table 19. Global GLP-1 Injection Production Market Share by Region (2027-2032) Table 20. Global GLP-1 Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global GLP-1 Injection Revenue by Region (2021-2026) & (US$ Million) Table 22. Global GLP-1 Injection Revenue by Region (2027-2032) & (US$ Million) Table 23. Global GLP-1 Injection Revenue Market Share by Region (2021-2026) Table 24. Global GLP-1 Injection Revenue Market Share by Region (2027-2032) Table 25. Global GLP-1 Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 26. Global GLP-1 Injection Sales by Region (2021-2026) & (Units) Table 27. Global GLP-1 Injection Sales by Region (2027-2032) & (Units) Table 28. Global GLP-1 Injection Sales Market Share by Region (2021-2026) Table 29. Global GLP-1 Injection Sales Market Share by Region (2027-2032) Table 30. Global GLP-1 Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 31. Global GLP-1 Injection Revenue Market Share by Manufacturers (2021-2026) Table 32. Global GLP-1 Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 33. Global GLP-1 Injection Sales Market Share by Manufacturers (2021-2026) Table 34. Global GLP-1 Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 35. Global GLP-1 Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 36. Global GLP-1 Injection Key Manufacturers Manufacturing Sites & Headquarters Table 37. Global GLP-1 Injection Manufacturers, Product Type & Application Table 38. Global GLP-1 Injection Manufacturers Commercialization Time Table 39. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 40. Global GLP-1 Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 41. Global GLP-1 Injection Revenue by Type (2021-2026) & (US$ Million) Table 42. Global GLP-1 Injection Revenue by Type (2027-2032) & (US$ Million) Table 43. Global GLP-1 Injection Revenue Market Share by Type (2021-2026) Table 44. Global GLP-1 Injection Revenue Market Share by Type (2027-2032) Table 45. Global GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 46. Global GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 47. Global GLP-1 Injection Sales Market Share by Type (2021-2026) Table 48. Global GLP-1 Injection Sales Market Share by Type (2027-2032) Table 49. Global GLP-1 Injection Price by Type (2021-2026) & (US$/Unit) Table 50. Global GLP-1 Injection Price by Type (2027-2032) & (US$/Unit) Table 51. Global GLP-1 Injection Revenue by Application (2021-2026) & (US$ Million) Table 52. Global GLP-1 Injection Revenue by Application (2027-2032) & (US$ Million) Table 53. Global GLP-1 Injection Revenue Market Share by Application (2021-2026) Table 54. Global GLP-1 Injection Revenue Market Share by Application (2027-2032) Table 55. Global GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 56. Global GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 57. Global GLP-1 Injection Sales Market Share by Application (2021-2026) Table 58. Global GLP-1 Injection Sales Market Share by Application (2027-2032) Table 59. Global GLP-1 Injection Price by Application (2021-2026) & (US$/Unit) Table 60. Global GLP-1 Injection Price by Application (2027-2032) & (US$/Unit) Table 61. Zhengda Tianqing Company Information Table 62. Zhengda Tianqing Business Overview Table 63. Zhengda Tianqing GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Zhengda Tianqing GLP-1 Injection Product Portfolio Table 65. Zhengda Tianqing Recent Development Table 66. Innovent Biologics Company Information Table 67. Innovent Biologics Business Overview Table 68. Innovent Biologics GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Innovent Biologics GLP-1 Injection Product Portfolio Table 70. Innovent Biologics Recent Development Table 71. Wanbang Biopharma Company Information Table 72. Wanbang Biopharma Business Overview Table 73. Wanbang Biopharma GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Wanbang Biopharma GLP-1 Injection Product Portfolio Table 75. Wanbang Biopharma Recent Development Table 76. Sihuan Pharmaceuticals Company Information Table 77. Sihuan Pharmaceuticals Business Overview Table 78. Sihuan Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio Table 80. Sihuan Pharmaceuticals Recent Development Table 81. CSPC Pharmaceutical Group Company Information Table 82. CSPC Pharmaceutical Group Business Overview Table 83. CSPC Pharmaceutical Group GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio Table 85. CSPC Pharmaceutical Group Recent Development Table 86. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 87. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 88. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio Table 90. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 91. Pegbio Company Information Table 92. Pegbio Business Overview Table 93. Pegbio GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pegbio GLP-1 Injection Product Portfolio Table 95. Pegbio Recent Development Table 96. Eli Lilly Company Information Table 97. Eli Lilly Business Overview Table 98. Eli Lilly GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Eli Lilly GLP-1 Injection Product Portfolio Table 100. Eli Lilly Recent Development Table 101. Huadong Medicine Company Information Table 102. Huadong Medicine Business Overview Table 103. Huadong Medicine GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Huadong Medicine GLP-1 Injection Product Portfolio Table 105. Huadong Medicine Recent Development Table 106. Hongyun Huaning Company Information Table 107. Hongyun Huaning Business Overview Table 108. Hongyun Huaning GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hongyun Huaning GLP-1 Injection Product Portfolio Table 110. Hongyun Huaning Recent Development Table 111. Hengrui Medicine Company Information Table 112. Hengrui Medicine Business Overview Table 113. Hengrui Medicine GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Hengrui Medicine GLP-1 Injection Product Portfolio Table 115. Hengrui Medicine Recent Development Table 116. Hansoh Pharmaceuticals Company Information Table 117. Hansoh Pharmaceuticals Business Overview Table 118. Hansoh Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio Table 120. Hansoh Pharmaceuticals Recent Development Table 121. Gan & Lee Pharmaceuticals Company Information Table 122. Gan & Lee Pharmaceuticals Business Overview Table 123. Gan & Lee Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio Table 125. Gan & Lee Pharmaceuticals Recent Development Table 126. Borui Pharmaceuticals Company Information Table 127. Borui Pharmaceuticals Business Overview Table 128. Borui Pharmaceuticals GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Borui Pharmaceuticals GLP-1 Injection Product Portfolio Table 130. Borui Pharmaceuticals Recent Development Table 131. Imeik Company Information Table 132. Imeik Business Overview Table 133. Imeik GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Imeik GLP-1 Injection Product Portfolio Table 135. Imeik Recent Development Table 136. Novo Nordisk Company Information Table 137. Novo Nordisk Business Overview Table 138. Novo Nordisk GLP-1 Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Novo Nordisk GLP-1 Injection Product Portfolio Table 140. Novo Nordisk Recent Development Table 141. North America GLP-1 Injection Revenue by Type (2021-2026) & (US$ Million) Table 142. North America GLP-1 Injection Revenue by Type (2027-2032) & (US$ Million) Table 143. North America GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 144. North America GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 145. North America GLP-1 Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 146. North America GLP-1 Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 147. North America GLP-1 Injection Revenue by Application (2021-2026) & (US$ Million) Table 148. North America GLP-1 Injection Revenue by Application (2027-2032) & (US$ Million) Table 149. North America GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 150. North America GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 151. North America GLP-1 Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 152. North America GLP-1 Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 153. North America GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America GLP-1 Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America GLP-1 Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 157. North America GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 158. North America GLP-1 Injection Sales by Country (2027-2032) & (Units) Table 159. North America GLP-1 Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 160. North America GLP-1 Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 161. United States GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 162. Canada GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 163. Mexico GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 164. Europe GLP-1 Injection Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe GLP-1 Injection Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 167. Europe GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 168. Europe GLP-1 Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Europe GLP-1 Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Europe GLP-1 Injection Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe GLP-1 Injection Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 173. Europe GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 174. Europe GLP-1 Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Europe GLP-1 Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Europe GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe GLP-1 Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe GLP-1 Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 180. Europe GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 181. Europe GLP-1 Injection Sales by Country (2027-2032) & (Units) Table 182. Europe GLP-1 Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Europe GLP-1 Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Germany GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 185. France GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 186. U.K. GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 187. Italy GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 188. Russia GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 189. Spain GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 190. Netherlands GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 191. Switzerland GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 192. Sweden GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 193. Poland GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 194. China GLP-1 Injection Revenue by Type (2021-2026) & (US$ Million) Table 195. China GLP-1 Injection Revenue by Type (2027-2032) & (US$ Million) Table 196. China GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 197. China GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 198. China GLP-1 Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 199. China GLP-1 Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 200. China GLP-1 Injection Revenue by Application (2021-2026) & (US$ Million) Table 201. China GLP-1 Injection Revenue by Application (2027-2032) & (US$ Million) Table 202. China GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 203. China GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 204. China GLP-1 Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 205. China GLP-1 Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia GLP-1 Injection Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia GLP-1 Injection Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 209. Asia GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 210. Asia GLP-1 Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Asia GLP-1 Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Asia GLP-1 Injection Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia GLP-1 Injection Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 215. Asia GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 216. Asia GLP-1 Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Asia GLP-1 Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia GLP-1 Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia GLP-1 Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 222. Asia GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 223. Asia GLP-1 Injection Sales by Country (2027-2032) & (Units) Table 224. Asia GLP-1 Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Asia GLP-1 Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Japan GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 227. South Korea GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 228. India GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 229. Australia GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 230. Taiwan GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 232. SAMEA GLP-1 Injection Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA GLP-1 Injection Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA GLP-1 Injection Sales by Type (2021-2026) & (Units) Table 235. SAMEA GLP-1 Injection Sales by Type (2027-2032) & (Units) Table 236. SAMEA GLP-1 Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 237. SAMEA GLP-1 Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 238. SAMEA GLP-1 Injection Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA GLP-1 Injection Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA GLP-1 Injection Sales by Application (2021-2026) & (Units) Table 241. SAMEA GLP-1 Injection Sales by Application (2027-2032) & (Units) Table 242. SAMEA GLP-1 Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 243. SAMEA GLP-1 Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 244. SAMEA GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA GLP-1 Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA GLP-1 Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 248. SAMEA GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 249. SAMEA GLP-1 Injection Sales by Country (2027-2032) & (Units) Table 250. SAMEA GLP-1 Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 251. SAMEA GLP-1 Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Brazil GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 253. Argentina GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 254. Chile GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 255. Colombia GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 256. Peru GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 258. Israel GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 259. UAE GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 260. Turkey GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 261. Iran GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 262. Egypt GLP-1 Injection Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. GLP-1 Injection Distributors List Table 266. GLP-1 Injection Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. GLP-1 Injection Product Image Figure 2. Global GLP-1 Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Injection Market Size Share 2021 VS 2025 VS 2032 Figure . Benaglutide Image Figure 1. Liraglutide Image Figure 2. Semaglutide Image Figure 3. Tirzepatide Image Figure 4. Others Image Figure 5. Global GLP-1 Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global GLP-1 Injection Market Size Share 2021 VS 2025 VS 2032 Figure 7. Diabetes Image Figure 8. Obesity Image Figure 9. Others Image Figure 10. Global GLP-1 Injection Capacity, Capacity Utilization (2021-2032) & (Units) Figure 11. Global GLP-1 Injection Production by Region: 2021 VS 2025 VS 2032 (Units) Figure 12. Global GLP-1 Injection Production Market Share by Region: 2025 Versus 2032 Figure 13. Global GLP-1 Injection Production Market Share by Region (2021-2032) Figure 14. North America GLP-1 Injection Production Growth Rate (2021-2032) & (Units) Figure 15. Europe GLP-1 Injection Production Growth Rate (2021-2032) & (Units) Figure 16. China GLP-1 Injection Production Growth Rate (2021-2032) & (Units) Figure 17. Japan GLP-1 Injection Production Growth Rate (2021-2032) & (Units) Figure 18. Global GLP-1 Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global GLP-1 Injection Revenue (2021-2032) & (US$ Million) Figure 20. Global GLP-1 Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global GLP-1 Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global GLP-1 Injection Revenue Market Share by Region (2021-2032) Figure 23. Global GLP-1 Injection Sales (2021-2032) & (Units) Figure 24. Global GLP-1 Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 25. Global GLP-1 Injection Sales Market Share by Region (2021-2032) Figure 26. North America GLP-1 Injection Sales YoY (2021-2032) & (Units) Figure 27. Europe GLP-1 Injection Sales YoY (2021-2032) & (Units) Figure 28. China GLP-1 Injection Sales YoY (2021-2032) & (Units) Figure 29. Asia (Excluding China) GLP-1 Injection Sales YoY (2021-2032) & (Units) Figure 30. South America, Middle East and Africa GLP-1 Injection Sales YoY (2021-2032) & (Units) Figure 31. Global GLP-1 Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global GLP-1 Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global GLP-1 Injection Revenue Market Share by Type (2021-2032) Figure 35. Global GLP-1 Injection Sales Market Share by Type (2021-2032) Figure 36. Global GLP-1 Injection Revenue Market Share by Application (2021-2032) Figure 37. Global GLP-1 Injection Sales Market Share by Application (2021-2032) Figure 38. North America GLP-1 Injection Revenue Share by Type (2021-2032) Figure 39. North America GLP-1 Injection Sales Share by Type (2021-2032) Figure 40. North America GLP-1 Injection Revenue Share by Application (2021-2032) Figure 41. North America GLP-1 Injection Sales Share by Application (2021-2032) Figure 42. North America GLP-1 Injection Revenue Share by Country (2021-2032) Figure 43. North America GLP-1 Injection Sales Share by Country (2021-2032) Figure 44. Europe GLP-1 Injection Revenue Share by Type (2021-2032) Figure 45. Europe GLP-1 Injection Sales Share by Type (2021-2032) Figure 46. Europe GLP-1 Injection Revenue Share by Application (2021-2032) Figure 47. Europe GLP-1 Injection Sales Share by Application (2021-2032) Figure 48. Europe GLP-1 Injection Revenue Share by Country (2021-2032) Figure 49. Europe GLP-1 Injection Sales Share by Country (2021-2032) Figure 50. China GLP-1 Injection Revenue Share by Type (2021-2032) Figure 51. China GLP-1 Injection Sales Share by Type (2021-2032) Figure 52. China GLP-1 Injection Revenue Share by Application (2021-2032) Figure 53. China GLP-1 Injection Sales Share by Application (2021-2032) Figure 54. Asia GLP-1 Injection Revenue Share by Type (2021-2032) Figure 55. Asia GLP-1 Injection Sales Share by Type (2021-2032) Figure 56. Asia GLP-1 Injection Revenue Share by Application (2021-2032) Figure 57. Asia GLP-1 Injection Sales Share by Application (2021-2032) Figure 58. Asia GLP-1 Injection Revenue Share by Country (2021-2032) Figure 59. Asia GLP-1 Injection Sales Share by Country (2021-2032) Figure 60. SAMEA GLP-1 Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA GLP-1 Injection Sales Share by Type (2021-2032) Figure 62. SAMEA GLP-1 Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA GLP-1 Injection Sales Share by Application (2021-2032) Figure 64. SAMEA GLP-1 Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA GLP-1 Injection Sales Share by Country (2021-2032) Figure 66. GLP-1 Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. GLP-1 Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Benaglutide
  • Liraglutide
  • Semaglutide
  • Tirzepatide
  • Others
Applications
  • Diabetes
  • Obesity
  • Others
Companies covered
  • Zhengda Tianqing
  • Innovent Biologics
  • Wanbang Biopharma
  • Sihuan Pharmaceuticals
  • CSPC Pharmaceutical Group
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • Pegbio
  • Eli Lilly
  • Huadong Medicine
  • Hongyun Huaning
  • Hengrui Medicine
  • Hansoh Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Borui Pharmaceuticals
  • Imeik
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GLP-1 Injection Market by Type
  3. 1.2.1 Global GLP-1 Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Benaglutide
  5. 1.2.3 Liraglutide
  6. 1.2.4 Semaglutide
  7. 1.2.5 Tirzepatide
  8. 1.2.6 Others
  9. 1.3 GLP-1 Injection Market by Application
  10. 1.3.1 Global GLP-1 Injection Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Diabetes
  12. 1.3.3 Obesity
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 GLP-1 Injection Market Dynamics
  1. 2.1 GLP-1 Injection Industry Trends
  2. 2.2 GLP-1 Injection Industry Drivers
  3. 2.3 GLP-1 Injection Industry Opportunities and Challenges
  4. 2.4 GLP-1 Injection Industry Restraints
3 Global GLP-1 Injection Production Overview
  1. 3.1 Global GLP-1 Injection Production Capacity (2021-2032)
  2. 3.2 Global GLP-1 Injection Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global GLP-1 Injection Production by Region
  4. 3.3.1 Global GLP-1 Injection Production by Region (2021-2026)
  5. 3.3.2 Global GLP-1 Injection Production by Region (2027-2032)
  6. 3.3.3 Global GLP-1 Injection Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global GLP-1 Injection Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global GLP-1 Injection Revenue by Region
  3. 4.2.1 Global GLP-1 Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global GLP-1 Injection Revenue by Region (2021-2026)
  5. 4.2.3 Global GLP-1 Injection Revenue by Region (2027-2032)
  6. 4.2.4 Global GLP-1 Injection Revenue Market Share by Region (2021-2032)
  7. 4.3 Global GLP-1 Injection Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global GLP-1 Injection Sales by Region
  9. 4.4.1 Global GLP-1 Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global GLP-1 Injection Sales by Region (2021-2026)
  11. 4.4.3 Global GLP-1 Injection Sales by Region (2027-2032)
  12. 4.4.4 Global GLP-1 Injection Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global GLP-1 Injection Revenue by Manufacturers
  2. 5.1.1 Global GLP-1 Injection Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global GLP-1 Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global GLP-1 Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global GLP-1 Injection Sales by Manufacturers
  6. 5.2.1 Global GLP-1 Injection Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global GLP-1 Injection Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global GLP-1 Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global GLP-1 Injection Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global GLP-1 Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global GLP-1 Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global GLP-1 Injection Manufacturers, Product Type & Application
  13. 5.7 Global GLP-1 Injection Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global GLP-1 Injection Market CR5 and HHI
  16. 5.8.2 2025 GLP-1 Injection Tier 1, Tier 2, and Tier 3
6 GLP-1 Injection Market by Type
  1. 6.1 Global GLP-1 Injection Revenue by Type
  2. 6.1.1 Global GLP-1 Injection Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global GLP-1 Injection Revenue Market Share by Type (2021-2032)
  4. 6.2 Global GLP-1 Injection Sales by Type
  5. 6.2.1 Global GLP-1 Injection Sales by Type (2021-2032) & (Units)
  6. 6.2.2 Global GLP-1 Injection Sales Market Share by Type (2021-2032)
  7. 6.3 Global GLP-1 Injection Price by Type
7 GLP-1 Injection Market by Application
  1. 7.1 Global GLP-1 Injection Revenue by Application
  2. 7.1.1 Global GLP-1 Injection Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global GLP-1 Injection Revenue Market Share by Application (2021-2032)
  4. 7.2 Global GLP-1 Injection Sales by Application
  5. 7.2.1 Global GLP-1 Injection Sales by Application (2021-2032) & (Units)
  6. 7.2.2 Global GLP-1 Injection Sales Market Share by Application (2021-2032)
  7. 7.3 Global GLP-1 Injection Price by Application
8 Company Profiles
  1. 8.1 Zhengda Tianqing
  2. 8.1.1 Zhengda Tianqing Company Information
  3. 8.1.2 Zhengda Tianqing Business Overview
  4. 8.1.3 Zhengda Tianqing GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Zhengda Tianqing GLP-1 Injection Product Portfolio
  6. 8.1.5 Zhengda Tianqing Recent Developments
  7. 8.2 Innovent Biologics
  8. 8.2.1 Innovent Biologics Company Information
  9. 8.2.2 Innovent Biologics Business Overview
  10. 8.2.3 Innovent Biologics GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Innovent Biologics GLP-1 Injection Product Portfolio
  12. 8.2.5 Innovent Biologics Recent Developments
  13. 8.3 Wanbang Biopharma
  14. 8.3.1 Wanbang Biopharma Company Information
  15. 8.3.2 Wanbang Biopharma Business Overview
  16. 8.3.3 Wanbang Biopharma GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Wanbang Biopharma GLP-1 Injection Product Portfolio
  18. 8.3.5 Wanbang Biopharma Recent Developments
  19. 8.4 Sihuan Pharmaceuticals
  20. 8.4.1 Sihuan Pharmaceuticals Company Information
  21. 8.4.2 Sihuan Pharmaceuticals Business Overview
  22. 8.4.3 Sihuan Pharmaceuticals GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio
  24. 8.4.5 Sihuan Pharmaceuticals Recent Developments
  25. 8.5 CSPC Pharmaceutical Group
  26. 8.5.1 CSPC Pharmaceutical Group Company Information
  27. 8.5.2 CSPC Pharmaceutical Group Business Overview
  28. 8.5.3 CSPC Pharmaceutical Group GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio
  30. 8.5.5 CSPC Pharmaceutical Group Recent Developments
  31. 8.6 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  32. 8.6.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  33. 8.6.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio
  36. 8.6.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  37. 8.7 Pegbio
  38. 8.7.1 Pegbio Company Information
  39. 8.7.2 Pegbio Business Overview
  40. 8.7.3 Pegbio GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Pegbio GLP-1 Injection Product Portfolio
  42. 8.7.5 Pegbio Recent Developments
  43. 8.8 Eli Lilly
  44. 8.8.1 Eli Lilly Company Information
  45. 8.8.2 Eli Lilly Business Overview
  46. 8.8.3 Eli Lilly GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly GLP-1 Injection Product Portfolio
  48. 8.8.5 Eli Lilly Recent Developments
  49. 8.9 Huadong Medicine
  50. 8.9.1 Huadong Medicine Company Information
  51. 8.9.2 Huadong Medicine Business Overview
  52. 8.9.3 Huadong Medicine GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Huadong Medicine GLP-1 Injection Product Portfolio
  54. 8.9.5 Huadong Medicine Recent Developments
  55. 8.10 Hongyun Huaning
  56. 8.10.1 Hongyun Huaning Company Information
  57. 8.10.2 Hongyun Huaning Business Overview
  58. 8.10.3 Hongyun Huaning GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Hongyun Huaning GLP-1 Injection Product Portfolio
  60. 8.10.5 Hongyun Huaning Recent Developments
  61. 8.11 Hengrui Medicine
  62. 8.11.1 Hengrui Medicine Company Information
  63. 8.11.2 Hengrui Medicine Business Overview
  64. 8.11.3 Hengrui Medicine GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Hengrui Medicine GLP-1 Injection Product Portfolio
  66. 8.11.5 Hengrui Medicine Recent Developments
  67. 8.12 Hansoh Pharmaceuticals
  68. 8.12.1 Hansoh Pharmaceuticals Company Information
  69. 8.12.2 Hansoh Pharmaceuticals Business Overview
  70. 8.12.3 Hansoh Pharmaceuticals GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio
  72. 8.12.5 Hansoh Pharmaceuticals Recent Developments
  73. 8.13 Gan & Lee Pharmaceuticals
  74. 8.13.1 Gan & Lee Pharmaceuticals Company Information
  75. 8.13.2 Gan & Lee Pharmaceuticals Business Overview
  76. 8.13.3 Gan & Lee Pharmaceuticals GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio
  78. 8.13.5 Gan & Lee Pharmaceuticals Recent Developments
  79. 8.14 Borui Pharmaceuticals
  80. 8.14.1 Borui Pharmaceuticals Company Information
  81. 8.14.2 Borui Pharmaceuticals Business Overview
  82. 8.14.3 Borui Pharmaceuticals GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 8.14.4 Borui Pharmaceuticals GLP-1 Injection Product Portfolio
  84. 8.14.5 Borui Pharmaceuticals Recent Developments
  85. 8.15 Imeik
  86. 8.15.1 Imeik Company Information
  87. 8.15.2 Imeik Business Overview
  88. 8.15.3 Imeik GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 8.15.4 Imeik GLP-1 Injection Product Portfolio
  90. 8.15.5 Imeik Recent Developments
  91. 8.16 Novo Nordisk
  92. 8.16.1 Novo Nordisk Company Information
  93. 8.16.2 Novo Nordisk Business Overview
  94. 8.16.3 Novo Nordisk GLP-1 Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 8.16.4 Novo Nordisk GLP-1 Injection Product Portfolio
  96. 8.16.5 Novo Nordisk Recent Developments
9 North America
  1. 9.1 North America GLP-1 Injection Market Size by Type
  2. 9.1.1 North America GLP-1 Injection Revenue by Type (2021-2032)
  3. 9.1.2 North America GLP-1 Injection Sales by Type (2021-2032)
  4. 9.1.3 North America GLP-1 Injection Price by Type (2021-2032)
  5. 9.2 North America GLP-1 Injection Market Size by Application
  6. 9.2.1 North America GLP-1 Injection Revenue by Application (2021-2032)
  7. 9.2.2 North America GLP-1 Injection Sales by Application (2021-2032)
  8. 9.2.3 North America GLP-1 Injection Price by Application (2021-2032)
  9. 9.3 North America GLP-1 Injection Market Size by Country
  10. 9.3.1 North America GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America GLP-1 Injection Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe GLP-1 Injection Market Size by Type
  2. 10.1.1 Europe GLP-1 Injection Revenue by Type (2021-2032)
  3. 10.1.2 Europe GLP-1 Injection Sales by Type (2021-2032)
  4. 10.1.3 Europe GLP-1 Injection Price by Type (2021-2032)
  5. 10.2 Europe GLP-1 Injection Market Size by Application
  6. 10.2.1 Europe GLP-1 Injection Revenue by Application (2021-2032)
  7. 10.2.2 Europe GLP-1 Injection Sales by Application (2021-2032)
  8. 10.2.3 Europe GLP-1 Injection Price by Application (2021-2032)
  9. 10.3 Europe GLP-1 Injection Market Size by Country
  10. 10.3.1 Europe GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe GLP-1 Injection Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China GLP-1 Injection Market Size by Type
  2. 11.1.1 China GLP-1 Injection Revenue by Type (2021-2032)
  3. 11.1.2 China GLP-1 Injection Sales by Type (2021-2032)
  4. 11.1.3 China GLP-1 Injection Price by Type (2021-2032)
  5. 11.2 China GLP-1 Injection Market Size by Application
  6. 11.2.1 China GLP-1 Injection Revenue by Application (2021-2032)
  7. 11.2.2 China GLP-1 Injection Sales by Application (2021-2032)
  8. 11.2.3 China GLP-1 Injection Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia GLP-1 Injection Market Size by Type
  2. 12.1.1 Asia GLP-1 Injection Revenue by Type (2021-2032)
  3. 12.1.2 Asia GLP-1 Injection Sales by Type (2021-2032)
  4. 12.1.3 Asia GLP-1 Injection Price by Type (2021-2032)
  5. 12.2 Asia GLP-1 Injection Market Size by Application
  6. 12.2.1 Asia GLP-1 Injection Revenue by Application (2021-2032)
  7. 12.2.2 Asia GLP-1 Injection Sales by Application (2021-2032)
  8. 12.2.3 Asia GLP-1 Injection Price by Application (2021-2032)
  9. 12.3 Asia GLP-1 Injection Market Size by Country
  10. 12.3.1 Asia GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia GLP-1 Injection Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA GLP-1 Injection Market Size by Type
  2. 13.1.1 SAMEA GLP-1 Injection Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA GLP-1 Injection Sales by Type (2021-2032)
  4. 13.1.3 SAMEA GLP-1 Injection Price by Type (2021-2032)
  5. 13.2 SAMEA GLP-1 Injection Market Size by Application
  6. 13.2.1 SAMEA GLP-1 Injection Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA GLP-1 Injection Sales by Application (2021-2032)
  8. 13.2.3 SAMEA GLP-1 Injection Price by Application (2021-2032)
  9. 13.3 SAMEA GLP-1 Injection Market Size by Country
  10. 13.3.1 SAMEA GLP-1 Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA GLP-1 Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA GLP-1 Injection Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 GLP-1 Injection Value Chain Analysis
  2. 14.1.1 GLP-1 Injection Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 GLP-1 Injection Production Mode & Process
  6. 14.2 GLP-1 Injection Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 GLP-1 Injection Distributors
  9. 14.2.3 GLP-1 Injection Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst